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 The purpose of this study was to investigate the effects of ammonia as a stimulant 
on athletic performance during a deadlift one maximal repetition (1-RM) absolute 
strength test. It was hypothesized that ammonia inhalation would result in a larger 1-RM, 
possibly due to immediate catecholamine release attributed to the fight-or-flight response. 
If proven effective, ammonia inhalation would present an option to increase power and 
strength performance during training  and competition based on an acute manipulation of 
natural occurring hormones, eliminating the side effects attributed to other 
supplementation methods. Subjects (n = 10 males, X±SD age = 21±1 years, mass = 
72.5±6.8 kg; n = 10 female, age = 22±5 years, mass = 66.2±8.1 kg) were required to have 
at least two years of resistance training experience while lacking a history of asthma, 
lightheadedness, fainting, anaphylaxis, sickle cell traits, and other respiratory disorders. 
After a baseline 1-RM test, subjects were paired by 1-RM performance and gender, then 
randomly assigned in a counterbalanced treatment order to control/blinding water or 
ammonia trials after a minimum 72-hour recovery period for another 1-RM test involving 
attempts at 100%, 102.5%, 105%, and 107.5% of the established 1-RM value. Testing 
was then repeated after the minimum rest period for the remaining trial. Results revealed 
the expected sex main effect for dead lift 1-RM (93.0±29.5 [females]; 152.0±29.5 kg 




by trial interaction effect (baseline = 93.0±15.3; 151.8±42.3 kg; water = 92.0±12.5; 
150.9±37.8 kg; ammonia = 92.5±16.4; 153.4±37.9 kg) for females and males, 
respectively (2,36F = 0.591, p = 0.559). Limitations to this study included the possibility 
that the delivery system was flawed; usage of an ammonia concentration not potent 
enough; and other extraneous factors. Within the limitations of this study, there is no 
basis for the support of ammonia inhalation to improve 1-RM efforts in training, 
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CHAPTER I – INTRODUCTION 
 
 Over the course of history, changes in scoring, participation, regulations, 
equipment, and athleticism requirements have been introduced to all sports. With some of 
these changes, the lines of legal and illegal performance have become blurred (Kisaalita 
& Robinson 2014). In addition to the introduction of technologically superior equipment 
and materials, supplements such as steroids have become the center of sports 
enhancement, with coaches and athletes often years or decades ahead of regulatory 
agencies. Many of these substances are currently in use to artificially increase the levels 
of testosterone, human growth hormone, and other performance-enhancing hormones for 
the purpose of improving both chronic and acute performance. 
  Anabolic supplements can be utilized by strength and power athletes over a 
long-term period to increase overall strength, power, muscle mass, and fat loss. Other 
methods are favored for their ability to mimic natural physiological processes such as 
adapting to a hypoxic environment while training at higher altitudes (which is allowed by 
the World Anti-Doping Agency [WADA]) without the need to actually train at altitude.  
While some substances are utilized for their acute effects and others for more chronic 
adaptations, some of these known supplements have been banned by most, if not all, 
drug-monitoring athletic agencies (Ramachandra et al., 2012). Positive results are based 
on the detection of prohibited substances, their metabolites, and markers in biological 
samples supplied by athletes; usually at a randomized and unknown time and place. As 
stated by the WADA, substances classified as “exogenous” refer to those that cannot 





produced by the body. What links these substances together is that they all not only target 
a specific hormone, but they often are designed to mimic its effects or prevent any side-
effects of its greater presence, while increasing the substance’s levels in the body to 
abnormally high concentrations. Increased concentrations of banned substances and/or 
any metabolites are criteria for a positive test and possible suspension and/or 
disqualification of the athlete. The WADA classifies these substances as banned from 
competition through the following criteria: 1) enhances performance, 2) represents a risk 
to health, and 3) violates the “spirit of sport” (Savelescu et al., 2004). Within these 
criteria, it is possible for athletes to utilize steroids for medical purposes where that intake 
is prescribed as a component of a treatment for health, rehabilitative, or preventative 
measures.  
However, these benefits to performance come at a cost, as many of these 
supplements have negative long-term consequences ranging from mental health 
(Lindqvist et al., 2013), structural, circulatory changes and responses (Boyadjiev et al., 
2010), organ complications, to even death (Montisci et al., 2012). Hence, the purpose of 
this study is to find an alternate method of enhancing acute strength performance while 
eliminating any negative chronic consequences. It has been suggested (Gorguner & 
Akgun, 2010) that there are few, if any, chronic consequences of acute inhalation injury 
from certain gaseous substances, in this case ammonia, when the proper precautions are 
taken. However, there is very little well designed research on the efficacy of ammonia 







STATEMENT OF PROBLEM 
 In today’s performance focused athletics, finding methods to increase 
performance, both in training and competition while not violating any regulations, has 
become a vital component in strength and conditioning programs at all levels of athletics 
from professional to high school competitions.  
  For the purpose of this study, the methodology was designed to observe the 
possibility of enhancing 1 repetition for maximal load lifts (1-RM) without the chronic 
consequences commonly associated with established methods of performance 
enhancement, specifically steroids and other such substances. The largest consideration is 
whether it is possible to influence the body’s natural endocrine systems and processes 
without any chronic side effects or consequences while staying within the current 
regulations in place by the WADA. Specifically, the goal of the current study was to 
examine the acute effect of inhaling small amounts of ammonia prior to performance of a 
strength exercise; in this case the deadlift exercise and the loads achieved in a standard 1-
RM test.  
 There are several methodological challenges with identifying any potential 
ergogenic effect caused by this inhalation. It is difficult to measure catecholamines 
(epinephrine, norepinephrine) and other stress hormones; hence the lack of measurement 
in this study and the assumption that acute sympathetic arousal is the mechanism for any 
observed ergogenic effect of ammonia inhalation. This is based on the assumption that 
the hypothalamic-pituitary-adrenal axis (HPA axis) is the origin of the mechanism 
causing the release of the catecholamines (epinephrine, norepinephrine, cortisol, ACTH, 





demonstrated that the HPA axis stimulates the release of cortisol from the adrenal gland 
as a reaction to stress (Embi & Scherlag, 2014). It has also been observed that there is no 
negative effect on HPA-axis stimulation in children after inhaling glucocorticosteroids 
(Wolthers & Honour, 1998). However, due to the speed of both the response to inhalation 
and the brief time frame of effect, it is assumed that sympathetic nervous system 
stimulation and the corresponding norepinephrine release is the focus of this study.  
Even though ammonia is an essential DNA, RNA, and protein synthesis 
metabolite for the maintenance of the acid-base balance (Gerberding, 2004), exposure to 
concentrated gases result in upper respiratory airway burns and obstructions, distress, and 
edema. However, acute exposure to 500 ppm levels or higher has also been shown to 
increase respiratory minute volume, which is well below the concentrations needed to the 
previously mentioned complications.  
NULL HYPOTHESIS (H0:) 
There will be no significant effect of the ammonia inhalant independent variable 
on 1-RM test results when compared to the control inhalant or the baseline 1-RM tests.  
RESEARCH HYPOTHESIS (HA:) 
The ammonia inhalant treatment will significantly increase 1-RM compared to the 
control inhalant and baseline treatments.  
ASSUMPTIONS 
 For the purpose of this study, it was assumed that all subjects, due to their 
resistance training experience, were performing the deadlift with proper form. It was also 
assumed that the subjects were familiar with 1-RM conditions, and were willing to exert 





effort. It was also assumed that all subjects did not change their daily routine during the 
duration of the testing trials, remained consistent with no changes to their personal 
training program, and had access to the same facilities and equipment over the past six 
months; thus minimizing bias based on environment and availability of resources for 
training. Finally, it was also assumed that subjects’ diets did not change, and there was no 
consumption of alternate or additional ergogenic or dietary supplements during the 
course of this study while still meeting the necessary caloric and nutritional consumption 
needed for their metabolic demands.  
DELIMITATIONS 
 In this study, the back squat and bench press are not being included despite their 
status as commonly tested multi-joint exercises due to the limited or non-existent data on 
the deadlift exercise. This was based on filling the current lack on scientific knowledge, 
while also allowing minimal training to be required to effectively perform the simple 
technique of the deadlift. This study was also focusing on subjects from the ages of 18 to 
24 years due to the high relevancy of the topic in question to athletes of similar ages.  
This is the same age group where many athletes are on the brink of professional careers, 
and often where they are looking for any methods, banned or otherwise, that allows them 
to distinguish themselves within the vast numbers of rival athletes.  
LIMITATIONS 
 All testing took place at the Student Recreation Center at Old Dominion 
University, which may have limited data collection due to the lack of ideal testing 
locations. The only current deadlifting platform was located in the middle of the facility 





substantial quantity and range of verbal, visual, and physical distractions during testing. 
These stressors may have helped to replicate the environment found in many power-
lifting competition and athletic training settings.  Any lack of judgment on the 
researcher’s part pertaining to subjects reaching full hip, knee, and elbow extension for 
full control of the loads during these lifts could have resulted in false achieved lifts. Due 
to the fact that subjects were full time students, scheduling three trials around academic 
courses became a threat to the study. Steps were taken to standardize the testing time of 
day despite the length of time between trials to account for diurnal variation and other 
metabolic considerations to assure consistent experimental conditions.  
SIGNIFICANCE OF THE PROBLEM 
  This study could provide evidence for the ergogenic effect of ammonia inhalant, 
a legal external substance, in increasing acute muscular strength as measured by a 
deadlift 1-RM.  This would allow athletes to improve their performance during training 
and competition without using banned agents such as androgenic-anabolic steroids that 
have been banned by the WADA and have harmful effects on health.   





CHAPTER II – REVIEW OF THE LITERATURE 
 
BACKGROUND 
 For most sports, it is difficult to achieve the desired success without a significant 
amount of strength to assist with the athletic demands in a particular sport. Strength 
training is one way to target both the neural and muscular components of muscular 
adaptation, stressing the central nervous system while impacting the increase in muscle 
mass. Methods used to target muscular adaptations include adjusting the intensity, scope 
of work, duration, rest periods, and loads involved. The ideal program chooses the 
methods that will produce the greatest effects in the shortest time period possible. Most 
fitness professionals in today’s professional, collegiate, and recreationally competitive 
society favor this approach.   
RESISTANCE TRAINING 
Due to the complexity of strength as a concept, it is necessary to break it down 
into specific components. There are four basic methods of achieving maximal muscular 
effort: lifting maximal resistance (the method of maximal effort), lifting submaximal 
resistance to failure (repetitive effort) (Stankovic et al., 2013), lifting resistance as fast as 
possible, termed dynamic effort; and lifting a submaximal load at a moderate volume of 
repetitions for as the method of submaximal effort. In this investigation, we are 
examining the lifting maximal resistance method to supplement the established research 
(Richmond et al., 2014) on submaximal resistance to failure due to the acute effects of 
inhalants to maximize their effect on the sympathetic nervous system. To test this 





lift only once in a slow, constant velocity (Baechle & Earle, 2008). The maximal 
resistance method is considered as the most effective for improving intra- and inter-
muscular coordination and maximizing the effects of strength training. This method 
requires the largest number of motor units with the best discharge frequency of the 
nervous system (Stankovic et al., 2013). Although there is an inherent risk of injury due 
to the load involved as well as increased conditions for muscle hypertrophy, this remains 
the preferred method for measuring absolute strength for programming purposes. The 
advantages of the maximal effort method in terms of muscle activation and adaptation 
outweigh the disadvantages of having developed form, strength, and proper testing 
progression at lower intensities; although this is without any supporting research 
(Baechle & Earle, 2008; Ch. 12). The data obtained from the maximal effort method 
allows the researcher to utilize mathematics to identify the intensities, loads, and 
durations necessary to achieve the desired results in the athlete. 
ENDOCRINE SYSTEM 
Strength training has an effect on all of the body’s internal systems, including the 
endocrine system, in particular the testosterone level.  During strength training, 
testosterone is released to meet the demands placed on the body.  This occurs in order to 
control protein synthesis, muscular development, bone growth, and calcium retention   
(Stankovic et al., 2013). Testosterone release as a result of resistance training is related to 
the size of the exercising muscle mass, the total volume of training (defined as resistance 
x repetitions x sets), and total duration of the training, with a higher emphasis being 
placed on intensity as the main factor to alter catecholamine responses to exercise 





manipulation of the catecholamine response only, ignoring any other resulting effects or 
stimulated chemical reactions in response to ammonia inhalation. However, due to the 
lack of proper testing equipment and facilities, this study will be assuming that the 
release of any hormones as a result of the ammonia inhalation is the HPA-axis-
facilitating homeostasis maintenance (Silverman et al., 2005). The HPA axis has also 
been observed as an avenue to respond to stress, which causes the release of metabolic 
factors such as cortisol into the blood causing an increase in cardiac tissue glycogen 
concentration levels (Embi & Scherlag, 2014). Although this study is not relating to the 
phosphogen system focus of this study, it did demonstrate the effect of stress on 
intramuscular substances affecting performance. In essence, the HPA axis responds to 
psychological and physical stressors by utilizing the neuroendocrine feedback loop to 
maintain or return to homeostasis (Handa & Weiser 2013). There seems to be no prior 
research suggesting or identifying any effect on reflex up-regulation or motor 
recruitment, suggesting that all targets and methods of influence are focused on hormonal 
release or retention and receptor activity to achieve the desired influences on 
performance. 
PHYSIOLOGICAL EFFECT OF INHALANTS 
Due to its highly irritating nature, ammonia inhalation causes rapid eye, nose, and 
throat irritation, coughing, and possibly bronchospasms even at low concentrations. 
However, due to its low odor threshold there is an early warning of its presence, and 
olfactory adaptation and desensitization can occur and render it less detectable (Gorguner 
& Akgun, 2010). When ammonia is inhaled, it forms ammonium hydroxide by reacting 





immediate laryngospasm and laryngeal edema, while severe exposure can lead to non-
cardiogenic pulmonary edema, residual chronic lung disease in the forms of bronchitis, 
bronchiectasis, airflow obstruction, interstitial fibrosis, and impaired gas exchange. These 
acute effects are well known, and although there is less research on the long-term effects 
of ammonia inhalation, it is thought that the extent of respiratory injury is dependent on 
the duration of exposure, gas concentration, and depth of inhalation (Leduc et al., 1992). 
This study included the preventative steps of utilizing small amounts of inhalants for a 
brief, split-second inhalation. Subjects were exposed to brief ammonia inhalation a total 
of six times throughout the study, and never within twenty-four hours of each instance, 
minimizing both the duration and depth of the exposure. These brief exposures are 
consistent with anecdotal observations of inhalant use by weight lifters in training and 
competition. 
 Ammonia products are included in basic first aid kits in the forms of smelling 
salts, ammonia capsules, and other products that are designed for preventing and treating 
lightheadedness, fainting and dizziness (Velasquez, 2011). Ammonia products are also 
being utilized for pre-lifting rituals before powerlifting attempts, “clearing an athlete’s 
head” in sporting events such as football and boxing, and overall “psyching up” of the 
individual. When inhaled, the ammonia instantaneously irritates the lungs, nose, and 
mucous membranes of the nasal cavity (Gorguner & Akgun, 2010). This irritation leads 
to an involuntary inhalation reflex while stimulating the respiratory muscles to a higher 
work rate, which is thought to achieve a higher degree of consciousness and is one focus 
of this study.  Although ammonia is considered to be a toxic substance, its inhalation is 





much greater than possible to achieve with over-the-counter products. There is an 
inherent risk for individuals with certain underlying complications, such as asthma, 
anaphylaxis, sickle cell traits, and other respiratory disorders. These potential 
complications emphasize the importance of knowing the athlete and taking the proper 
precautions with any respiratory issues, which may include rare usage, smaller dosages, 
or avoidance all together. In spite of these potential complications, all of these ammonia 
products are considered safe since they have met the requirements to be allowed in the 
inventory of a standard medical kit, which is much less than the amounts considered 
hazardous except in the absence of any underlying respiratory issues. However, in the 
interest of safety and liability, screening of subjects for these exclusionary criteria was 
conducted in this study despite the precaution of utilizing products considered safe for all 
circumstances.  
Past studies have utilized inhalants other than ammonia for the purpose of 
manipulating the muscular and endocrine systems for performance enhancement. Decorte 
et al., 2013, specifically observed the effects of salbutamol on neuromuscular function 
during a quadriceps fatigue test, observing that inhaled β2-agonists increased quadriceps 
endurance without any significant effect on neuromuscular activity in the form of 
maximum voluntary contraction readings. Prior to this study, Decorte et al., (2008) 
focused on both quadriceps fatigability and force output with the acute effects of 
salbutamol inhalation. They reported no effect on strength, fatigue, and recovery of the 
quadriceps in subjects without asthma. Similar findings were reported by Kindermann in 
2007 during a qualitative review of 19 studies, in which 17 showed null effects on 





effects following oral administration.  This is supported by another review (Pluim et al., 
2011), in which β2-agonists showed no significant effects on endurance, strength, or 
sprint performance in healthy athletes. Based on these reviews, there is scant evidence for 
an effect of inhaled β2 agonists on performance.   
PREVIOUS RESEARCH ON THE EFFECTS OF AMMONIA INHALANTS ON 
MUSCULAR STRENGTH 
Richmond et al., (2014) examined the effect of ammonia inhalants on bench press 
and squat strength exercises in twenty-five male subjects. Subjects performed a 
submaximal-load (85% of their 1-RM) maximal-repetition test. They found no difference 
in repetition performance between the inhalant and placebo trials.  The researchers 
attributed this to a possible need of a higher percentage of 1-RM. This change would 
better utilize the anaerobic energy system that ammonia inhalation is hypothesized to 
stimulate, and stay within the ideal time frame to utilize the effect of the ammonia, a time 
period in which this study may have exceeded.  
PREVIOUS RESEARCH ON INHALANTS AND EFFECTS ON 
PERFORMANCE 
In related studies, it has also been found that high-dose inhalations of salbutamol 
have no effect on aerobic capacity or oxygen uptake (Elers et al., 2012). However, this 
study also examined short-term performance of about 20-25 minutes of activity, where 
the immediate effect of inhalants and the induced responses as a result take full effect 
then decline within seconds of inhalation. Other studies have shown that inhalants could 
have an effect on performance even with this small window of effect if administered at 





cycling race increased sprint cycling performance at the end of the race (Bedi et al., 
1988). It has also been observed that usage of salbutamol (ß2-adrenergic agonist) 
inhalants do not have an ergogenic effect on performance during a 5 km race (Dickinson 
et al., 2014), where runners inhaled up to 1600 μg of salbutamol 15 minutes prior to 
racing. Their goal was to stimulate bronchodilation to reduce airway resistance with the 
result of increased oxygen minute ventilation and improved performance. Despite 
differences in energy systems, the goal of this study was similar to that of Dickinson et 
al., in 2014. Although this study was targeting a different inhalation response and energy 
system, the objective was similar to that of Dickinson’s study: stimulation of a beneficial 
response to inhalation of an involved system in the particular sport for a rapid and acute 
increase in athletic performance with little or no side effects or traces. However, unlike 
salbutamol, ammonia is not on the WADA prohibited substances list or even considered 
at this point to be a candidate to be added to that list, making it not only a potential 
ergogenic aid but also a legal one.  
CONCLUSION 
Research has shown ergogenic aids influence athletic performance through forced 
adaptations and overloading of existing bodily systems. Some ergogenic aids result in 
negative acute and chronic consequences. These consequences are the core reason why 
many of these substances are banned by the WADA, as well as the unfair advantage 
caused by their usage to increase existing bodily reactions and systems involved in 
desirable outcomes. However, these substances are only supplements to a training 





 According to Bedi, et al. (1988), substances that do not have any adaptation 
effects on natural occurring responses can be utilized to affect performance by dictating 
when these responses, such as catecholamine release, occur. Without any chronic 
adaptations, it has been observed that we can acutely influence the timing of beneficial 
reactions without tampering with the systems already naturally structured in the body. 
However, all of these tests have been conducted during moderate to long duration 
exercise, eliminating any true effects on performance due to the short duration of effect 
of the inhalants. 
The goal of this study was to examine the short-term consequences of ammonia 
inhalation on deadlift 1-repetition maximum.  Focusing on the deadlift, a short duration 
power exercise, eliminated the limitation of diminishing effects of ammonia inhalation on 
a task of longer duration. Taking advantage of the body’s natural fight-or-flight reactions 
and controlling the timing of their onset, the goal was to increase performance to the 







CHAPTER III – METHODS 
SUBJECTS 
Subjects were college aged male and female undergraduate students 
approximately 18-24 years of age. Subjects were recruited from the Exercise Science 
undergraduate program at Old Dominion University, specifically from the EXSC 250, 
Strength and Conditioning Leadership, in which they received extra credit points toward 
their lecture grade in that course with the instructor’s approval. If students showed 
interest in the study but did not meet the inclusionary criteria, they were allowed to 
submit a resistance training specific article report for the same credit points, which was 
made available for all students regardless of their interest in the study.  All subjects were 
required to have a minimum of two years of resistance training experience, specifically 
experience with the deadlift exercise. Participants with a history of asthma, 
lightheadedness, fainting, anaphylaxis, sickle cell traits, and other respiratory disorders 
were excluded from the study due to the risk of fainting, rapid and involuntary 
contraction of the neck and head for ammonia inhalation, and in significantly higher 
doses not available in over-the-counter products, toxicity, sickness, and death. A total of 
20 participants (10 females and 10 males) were recruited for the study. This study 
included the preventative steps of utilizing small amounts of inhalants two inches from 
the nose for a brief, split second inhalation. Subjects were only exposed a total of six 
times throughout the study, and never within twenty-four hours of each instance, 
minimizing both the duration and depth of the exposure.  Prior to all testing, the 





Participants received a verbal explanation of the study and provided written informed 
consent. 
DESIGN 
All subjects participated in a 1-RM test for the deadlift, with the subject 
progressively performing single repetitions in increasing heavier loads until they 
achieved one maximal effort that could not be surpassed by another effort. Equipment 
utilized in the study included a standard Rogue Fitness (Columbus, Ohio) Echo Series 
Bumper Plates (2.5, 5, 10, 15, 25, 35, 45, 55 pound options) and a standard 20-kg Rouge 
28MM Training Bar. Testing took place on a standard Olympic regulation weightlifting 
platform located in the Student Recreation Center (Pro-Maxima FW-147 8’ x 8’ 
platform). Subjects were allowed to use any weightlifting accessories such as Olympic 
weightlifting shoes, belts, sleeves, etc., and were required to use the same equipment and 
the same grip and lifting technique for all trials. The ammonia inhalant utilized in this 
study was Pac-Kit (South Norwalk, CT) Ammonia Inhalants medical kit refills (2.125" x 
4" x 0.625"), with the control substance being water in an identical bottle. Subjects 
should have been able to use their experience with the deadlift to achieve maximal effort 
within three to five repetitions of their initial warm-up, utilizing previous 1-RM tests as a 
guide to the load selection for their attempts. The loads selected for these attempts as well 
as the success and failure were recorded for testing design purposes during the trials later 
in the study. Subjects had a minimum of 72 hours between each session to allow for full 
recovery from their exertions and exposure to the particular inhalant in that trial.    
Subjects followed the procedures in Tables 1 and 2 for the initial baseline 1-RM 





ammonia supplementation or the control condition with water as the control substance. 
Subjects were paired within sex by similar 1-RM baseline results and randomly assigned 
to counterbalanced treatment orders. All substances involved in this study were stored in 
blank bottles by a fellow graduate student for the blinding of both the researcher and the 
research subjects. Using the data collected from the baseline maximal test, the researcher 
calculated the progressive increase in weight (in percent) per each attempt for the subject 
for both trials. Based on this information, subjects performed two repetitions at 65% and 
two at 75% 1-RM, and one repetition at 85%, 90%, and 95% of 1-RM, followed by the 
final attempt at either 100% and/or 100% and higher as stated in the following protocol. 
 
Table 1. Standardized warm-up for each trial 
1. 2 x 10 Fire Hydrants per leg 
2. 2 x 10 second Lunge Stretches 
3. 2 x 10 Dumbbell Good Mornings @ 10 & 20 pounds 
4. 1 x 10 @ Barbell 
5. 3 x 5 @ 45% 
6. 2 x 3 @ 50% 
 
For trial 1, the subject inhaled the assigned inhalant and attempted to lift 100% 1-
RM plus 2.5% of the 1-RM achieved in baseline testing.  In trial 2 the subject inhaled the 
same inhalant and attempted to lift 100% 1-RM plus 2.5, 5, and 7.5% respectively. In 
these two trials, the subject was asked to set their feet and all other personal necessities 
prior to the lift (tighten belt, set straps, etc.), take in one maximal inhalation from either 





inhalant are felt.  Trials were then repeated for the second inhalant with an identical 
process to Trial 1 and Trial 2 in Trial 3. If the subject failed an attempt, they were 
allowed a second attempt at the weight with identical procedures, including another 
inhalation of the prescribed inhalant. All subjects had a timed rest interval of three 
minutes between all attempts during this study for ideal recovery time without 
compromising performance (Matuszak et al., 2003).  
 
Table 2. TRIAL WEIGHT PROGRESSION BASED ON BASELINE 1-RM 
 Warm-up 65% 75% 85% 90% 95% 100% Trial 
 Baseline Methods 
Table 1 p. 17 




Table 1 p. 17 






Table 1 p. 17 




* Subject continues to perform single repetitions until a maximum lift was achieved that 









Counterbalanced Treatment Order (Trial Results)
1-RM Trial 3 (Remaining Trial)
72 Hour Minimum Recovery
1-RM Trial 2 (Water or Ammonia)
72-Hour Minimum Recovery








Baseline descriptive variables (age, height, mass, years of weightlifting 
experience) and 1-RM data for Trials 1, 2 and 3 were examined for normality.  1-RM 
data were analyzed with repeated-measures analysis of variance with Bonferroni 
adjustments for planned post-hoc comparisons using IBM SPSS (Version 21, Armonk, 
NY).  The criterion for statistical significance was be α=0.05. Unless otherwise indicated, 





CHAPTER IV – RESULTS 
 
Ten male and 10 female subjects completed all three testing sessions. Baseline 
characteristics are presented in Table 4.  As expected, males were significantly heavier 
and had greater (p≤0.05) absolute (kg) and relative (kg·kg-1) dead-lift performance. There 
were no reported issues or injuries from participation in the study outside of normal 
soreness and Delayed Onset of Muscle Soreness (DOMS) signs and symptoms. After 
testing was completed for all subjects, the ammonia was revealed to be contained in 
Bottle B, with Bottle A containing water for the controlled substance (Table 3). Matching 
of subjects in pairs according to baseline performance and randomized assignment to 
treatment order (water/ammonia; ammonia/water) resulted in no order effect (p=0.533).  
Table  4. Baseline characteristics of subjects.  Values are X ± SD. 
________________________________________________________________________ 
Variable     Females (n=10)   Males (n=10) 
Age (years)     22 ± 5    21 ± 1 
Body mass (kg)*    66 ± 8    75.2 ± 6.8 
Absolute Baseline dead-lift 1-RM (kg)* 93.0 ± 15.4   151.8 ± 42.3 
Relative Baseline dead-lift 1-RM (kg·kg-1)* 1.42 ± 0.27   2.01 ± 0.5 
________________________________________________________________________ 
*Males > Females, p≤0.05 
The effect of treatments on absolute dead-lift performance is presented in Figure 
1. As expected, there was a significant sex main effect (p<0.0001) in favor of males.  






Figure 1. Subject Absolute Deadlift comparison between trials. Values are X±SE. 
 
The effect of treatments on relative dead-lift performance is presented in Figure 2 
with all relative calculations based on body mass measured at baseline. Males had greater 
relative dead-lift strength across all trials compared to females (p<0.001), but there was 
no trial main effect (p=0.946) or sex by trial interaction effect (p=0.553). This indicated 






































Figure 2. Subject Relative Deadlift comparison between trials. Values are X±SE. 
 
As shown in Figure 3, percent changes in absolute dead-lift strength (water vs. 
baseline; ammonia vs. baseline; ammonia vs. water) were similar (p=0.869) with no 



















































































CHAPTER V – DISCUSSION 
 
Ammonia inhalants are often used during Olympic weightlifting and powerlifting 
events for the purpose of improving athletic performance in both competitive and training 
situations. However, this study has shown no significant difference in achieved 1-RM 
loads between maximal deadlift attempts with ammonia compared to water or baseline 
treatments in male and female recreational weightlifters. Although our data suggest there 
is no effect on performance, more research is needed on this topic with emphasis on 
ammonia concentration, greater recovery time allowed between trials, and standardizing 
the time between trials.  
 Subjects commented during ammonia experimental trials that the inhalant made 
them “more alert,” “more awake,” or “hyper-alert,” with confirming dilated eyes and 
increased respiratory rate as observed by the researcher during testing. There was some 
coughing as a result of the inhalant, although subjects exhibiting this response recovered 
within seconds of its onset. The order of trials did not have a significant effect on testing.  
One variable that this study failed to account for was the effect of final exams on the 
subjects involved in the research. All subjects were students finishing the spring semester 
of the 2015 school year; hence many subjects were not in their ideal or regular schedules 
and habits. Issues such as sleep deprivation, altered diet inactivity, scheduling, sickness 
(one subject, which more than likely was stress-induced from final exams between trials 
and did not mention the illness until after testing), and stress may have impacted the 
subjects’ performances. Training experience was another complication with the subjects. 





of both sexes had never tested their 1-RM for the deadlift, stating that their training goals 
never required knowledge of their maximal effort abilities, which may account for the 
slightly lower baseline achieved loads compared to the experimental trials in some 
subjects, and hints at their ability to achieve greater loads due to just never having been 
subjected to such a load. However, the absence of significant differences in deadlift 1-
RM between baseline and water or ammonia experimental conditions supports the 
absence of a learning effect as well as the hypothesized treatment effect.  With a subject 
pool of this background, submaximal testing may have been more ideal due to its design 
being more applicable to their training methods, but the focus of this study was 
measurement of maximal strength. The short-term efficacy of ammonia in improving 
deadlift 1-RM might be more apparent in more homogeneously experienced male and 
female powerlifters. One recommendation for future study is the replication of this design 
with such a study population against the utilized population of recreational lifters utilized 
in this study.    
Other uncontrolled variables in this study were the difference in techniques and 
equipment utilized. These were standardized within subjects but not across the subject 
pool in an effort to keep subjects in their ideal comfort state, as well as maintaining the 
methods they use to train while not introducing new variables to a familiar task. 
Approximately 33 percent of subjects used belts, which could have a significant effect on 
their performance due to the increase ability to create and hold pressure in the torso, 
allowing the maintenance of posture that would otherwise be compromised. One female 
subject also utilized powerlifting straps, which eliminated her grip from the lift, which is 





many different stances, grips, grip widths, and shoes were utilized by the subjects, all of 
which individually could have significant effects on the subject’s performance. These 
variations were expected due to different training goals, body mechanics, individual 
weaknesses and strengths, all which are included in the process of identifying the method 
used to perform the deadlift within the standard of reaching full torso, hip, and knee 
extension while lifting the barbell from the floor. However, there was no protocol to 
address any benefit of equipment or usage of different techniques within each subject and 
the overall subject population since that was not the focus of this study.  
For female subjects specifically, there was no tracking of the menstrual cycle, 
which also could have had an effect on performance if testing was performed during 
specific time frames of the cycle (Birch and Reilly, 2002), although overall there seems 
to be no observed effect based on this study’s findings. One female subject lifted 205 
pounds in her baseline trial, but only 185 pounds in the water trial, and then 155 pounds 
in the ammonia trial. This could have been due to inability to recover from prior trials, 
but the subject was shocked at her inability to reach her baseline value, which leaves the 
cause for her performance up for question.  
The concentration of the ammonia component could have also been a factor.  In 
many competitions, inhalants utilized can be up to three times the concentration of the 
capsules utilized in this study. These concentrations were not tested due to subject safety, 
with the focus being on the consistent amounts of fresh ammonia present in each capsule, 
where competition smelling salts come in “bulk” bottles and have to be resealed after 
each use. This study was also based on the assumption that ammonia is the substance 





Timing could also have been a confounding variable within the study in a few 
instances. Although each subject tested at the same time of day during the study, this was 
determined by availability, not by individual ideal training time. A given subject might 
have been in a more ideal training state in the afternoons, but was instead scheduled to 
test in the mornings. The timing of the maximal lift could have been an issue. Some 
subjects took longer to recover from the initial “hit” of the ammonia to the point where 
after the lift (which was within 20 seconds of inhalation) subjects were still recovering 
from the initial response to the ammonia. Future studies should standardize the time 
between lifts and inhalation, not seconds so that subjects can be in the desired heightened 
state, but have adequate time to begin returning to homeostasis. Although the 
standardized recovery time between trials was enforced, for some subjects there was an 
unexplained inability to fully return to homeostasis. There may be value in future studies 
to keep subjects within twenty seconds between inhalation and lifting, while testing 
different specific times within that range. 
A major limitation in this study was the bottles containing water and ammonia 
treatments. All substances were stored and administered in taped (for blinding) travel size 
shampoo bottles, which were all discarded after use. To administer the substance after 
shaking, the tester flipped open the cap of the bottle, where the subjects were inhaling the 
substance through the narrow opening of the lid, which was much smaller than the 
opening of the bottle itself. This taping of the capped bottle not only blinded the subject 
but the researcher as well through all trials. Although this was planned for the purpose of 
double-blinding, post-testing review reveals that the lids may have limited the subjects 





subjects from getting the full exposure to the ammonia, as well as eliminated the need for 
longer recovery time between inhalation and performing the lift. Future studies can also 
benefit from a modified protocol utilizing more trials over a greater time period, with two 
trials for both the water and ammonia treatments to provide more data on whether or not 
there is an effect attributed to the ammonia, while limiting the possibility of the subject 
being able to guess which substance is being utilized in that trial.  
Reviewing the only prior research related to this topic, there was similar findings 
by Richmond et al., in 2014 during submaximal testing of bench press and squat at 85% 
of baseline maximal testing while inhaling Vick’s VapoRub. Similar to this study, there 
was no observed differences between the experimental and blinding substances, while 
still recommending athletes can continue to utilize the substance without negative 
consequences to take advantage of any psychological effects due to usage, but at their 
own decision. Although this study focused on submaximal testing compared to maximal 
testing in this study, both studies are comparable, making two studies not finding any 







In conclusion, this study is the first to truly test the effects of ammonia inhalation 
on 1-RM testing. The acknowledged design flaws and limitations encountered in this 
study underscore the importance of additional investigation.  Future research should 
examine the effect of ammonia inhalation in a more experienced study group with better 
control over diurnal variations in strength measurement; potential effects of menstrual 
cycle phases in female subjects; use of standardized equipment and technique; and lifts in 
addition to the dead-lift. Within the limits of this study, there was no ergogenic effect of 
ammonia inhalation on dead-lift performance in recreational male and female 
weightlifters. Based on these findings, it is not recommended to strength and conditioning 
professionals to incorporate inhalants into their training programs. Given these findings, 
if athletes and/or coaches feel that ammonia inhalants have a psychological benefit for 
their programs, there is no basis to encourage or discourage their usage if their athlete has 
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Appendix 1- Subject Data 
Subject Age Weight Baseline Trial A Trial B 
F1 20 148 230 245 235 
F2 19 139 270 245 275 
F3 22 131 215 225 215 
F4 19 159 195 195 195 
F5 34 176 210 215 220 
F6 21 122 205 185 155 
F7 21 131 155 170 165 
F8 20 155 215 195 195 
F9 25 165 195 210 210 
F10 20 130 155 170 170 
M1 22 177 290 290 295 
M2 20 170 415 415 415 
M3 21 139 230 240 250 
M4 21 169.5 235 245 250 
M5 22 189 425 425 425 
M6 22 176 440 440 450 
M7 21 155.5 205 225 230 
M8 21 172.5 385 365 365 
M9 19 151 290 290 290 







EXSC 250, 240 Extra Credit Opportunity 
 
Subjects are needed for the following research study; participating will satisfy the current 
extra credit requirements stated in your course syllabus. Alternate opportunities are 
available if you do not met the requirements of participation in this study. 
 
The Effects of Pre - Maximal Exertion Inhalation of Gaseous Agents and the 
Performance Effects During Barbell Movements.  
 
It has been observed at Olympic weightlifting meets with multiple athletes 
inhaling fumes from ether a small bottle with an unknown substance, as well as actual 
ammonia capsules prior to stepping on the platform for their lifts. This usage, while 
obvious, has not been addressed or regulated due to ammonia (azane) not being in the 
World Anti-Doping Agencies list of prohibited substances. This may be due to lack on 
knowledge on its effects on performance, or because its effects are not severe/extreme 
enough to warrant being included in the prohibited list. In this study, ammonia inhalant 
capsules acquired from Pac-Kit First Aid safety Equipment Company will be utilized to 
address the stimulant that we assume is what has been seen utilized in competition. 
 
All subjects will undergo a 1-RM test for the deadlift, with the subject 
progressively performing single repetitions in increasing heavier loads until they have 





utilized in this study will be standard Rogue Fitness (Columbus, Ohio) Echo Series 
Bumper Plates (2.5, 5, 10, 15, 25, 35, 45, 55 pound options) which will be utilized with a 
standard 20-kg Rouge 28MM Training Bar, testing will take place on a standard Olympic 
regulation weightlifting platform. Any weightlifting accessories will be allowed such as 
Olympic weightlifting shoes, belts, sleeves, etc. Subjects must wear the same equipment 
for all trials, while also performing or utilizing the same grip and lifting technique for all 
trials. The ammonia inhalant being utilized in this study is Pac-Kit (South Norwalk, CT) 
Ammonia Inhalants medical kit refills (2.125" x 4" x 0.625"), with the control substance 
being water in an identical bottle. Subjects should use their experience with the deadlift 
to achieve maximal effort within three to five repetitions of their initial warm-up, 
utilizing previous 1-RM tests as a guide to the load selection for their attempts. The loads 
selected for these attempts as well as the success and failure will be recorded for testing 
design purposes during the trials later in the study. Subjects will have a minimum of 72-
hours between each session to allow for full recovery from their exertions and exposure 
to the particular inhalant in that trial.    
Subjects will follow the procedures in Table 1 for both the initial baseline 1-RM 
test as well as for the experimental trials, after being counter-balanced to either the 
experimental condition with the ammonia supplementation or the control condition with 
water as the control substance. Subjects with similar 1-RM baseline results and gender 
will be paired together for data analysis before the two experimental trials. All substances 
involved in this study will have been stored in blank bottles by a mentoring faculty 
member for the blinding of both the researcher and the research subjects. Using the data 





increase in weight (in percent) per each attempt for the subject for both trials. Based on 
this information, subjects will perform two repetitions at 65% and 75% 1-RM, and one 
repetition at 85%, 90%, and 95%, of 1-RM, followed by the final attempt at either 100% 
or 100% and higher. 
For trial 1, the subject will be inhaling the assigned inhalant and attempting to lift 
100% 1-RM plus 2.5% of the 1-RM achieved in baseline testing.  In trial 2 the subject 
will be inhaling the same inhalant and attempting to lift 100% 1-RM plus 5%. In these 
two trials, the subject will be asked to set their feet and all other personal necessities prior 
to the lift, take in one maximal inhalation from either bottle one or two and perform the 
lift within 15 seconds of inhalation as the effects of the inhalant are felt.  Trials will then 
be repeated for the second inhalant with an identical process to Trial 1 and Trial 2 in Trial 
3. If subject fails an attempt, they will be allowed a second attempt at the weight with 
identical procedures, including another inhalation of the prescribed inhalant. All subjects 
will have a timed rest interval of three minutes between all attempts during this study for 
ideal recovery time without compromising performance (Matuszak et al. 2003).  
 
Warm-up for Each Trial 
1. 2 x 10 Fire Hydrants per leg 
2. 2 x 10 second Lunge Stretches 
3. 2 x 10 Dumbbell Good Mornings @ 10 & 20 pounds 
4. 1 x 10 @ Barbell 
5. 3 x 5 @ 45% 









65% 75% 85% 90% 95% 100% Trial 
 Trial 1 Methods x 2@ x 2@ x 1@ x 1@ x 1@ x 1@ N/A 
 Trial 2 Methods x 2@ x 2@ x 1@ x 1@ x 1@ x 1@ RM + 
2.5% 
 Trial 3 Methods  x 2 @ x 2@ x 1@ x 1@ x 1@ x 1@ RM + 
5% 
 
*** By utilizing the subject’s bodyweight in the following formula, it will provide 
another method of analyzing any improvement in strength due to the acute effects of the 
prescribed inhalant.  







INFORMED CONSENT DOCUMENT 
OLD DOMINION UNIVERSITY 
PROJECT TITLE: The Effects of Pre - Maximal Exertion Inhalation of Ammonia 
Agents and the Performance Effects During Deadlift Maximal Testing. 
 
INTRODUCTION 
The purpose of this form are to give you information that may affect your 
decision whether to say YES or NO to participation in this research, and to record the 
consent of those who say YES. The Effects of Pre - Maximal Exertion Inhalation of 
Gaseous Agents and the Performance Effects During Barbell Movements. For the 
purpose of this study, the methodology is designed to observe the possibility of 
enhancing 1-RM (1 repetition for maximal load) lifts without the chronic consequences 
commonly associated with established methods of performance enhancement, 
specifically steroids and other such substances. The largest consideration is whether it is 
possible to influence the body’s natural endocrine systems and processes without any 
chronic side effects or consequences while staying within the current regulations in place 
by the WADA. Specifically, we are trying to determine the possibility to being able to 
utilize the acute consequences of inhaling small amounts of ammonia prior to 
performance of a power exercise; in this case the deadlift exercise and the loads achieved 









J. David Branch, B.A., M.S., Ph. D., Darden College of Education, HMS Associate 
Professor; Responsible Project Investigator 
 
Investigators 
Justin Vigil, B.S., Darden College of Education, HMS Masters Student.  
Phil Sabatini, B.S., M.S., HMS Lecturer 
DESCRIPTION OF RESEARCH STUDY 
The purpose of this study is to provide evidence for the ergogenic effect an 
ammonia inhalant, a legal external substance, in increasing acute muscular strength as 
measured by a deadlift 1-RM. This study is designed to assess the effect of ammonia 
inhalant on the subject group with that of a control group between an ammonia inhalant 
product and a water as a control substance. 
If you decide to participate, then you will join a study involving research of 
subjects will perform a 1-RM test for the deadlift, with you progressively performing 
single repetitions in increasing heavier loads until you have performed one maximal 
effort that cannot be surpassed by another effort. All subjects will undergo a 1-RM test 
for the deadlift, with the subject progressively performing single repetitions in increasing 
heavier loads until they have performed one maximal effort that cannot be surpassed by 
another effort. Equipment utilized in this study will be standard Rogue Fitness 
(Columbus, Ohio) Echo Series Bumper Plates (2.5, 5, 10, 15, 25, 35, 45, 55 pound 





will take place on a standard Olympic regulation weightlifting platform. Any 
weightlifting accessories will be allowed such as Olympic weightlifting shoes, belts, 
sleeves, etc. Subjects must wear the same equipment for all trials, while also performing 
or utilizing the same grip and lifting technique for all trials The ammonia inhalant being 
utilized in this study is Pac-Kit (South Norwalk, CT) Ammonia Inhalants medical kit 
refills (2.125" x 4" x 0.625"), with the control substance being water in an identical 
bottle. Subjects should use their experience with the deadlift to achieve maximal effort 
within three to five repetitions of their initial warm-up, utilizing previous 1-RM tests as a 
guide to the load selection for their attempts. The loads selected for these attempts as well 
as the success and failure will be recorded for testing design purposes during the trials 
later in the study. Subjects will have a minimum of 72-hours between each session to 
allow for full recovery from their exertions and exposure to the particular inhalant in that 
trial.    
Subjects will follow the procedures in Table 1 for both the initial baseline 1-RM 
test as well as for the experimental trials, after being counter-balanced to either the 
experimental condition with the ammonia supplementation or the control condition with 
water as the control substance. Subjects with similar 1-RM baseline results and gender 
will be paired together for data analysis before the two experimental trials. All substances 
involved in this study will have been stored in blank bottles by a mentoring faculty for 
the blinding of both the researcher and the research subjects. Using the data collected 
from the baseline maximal test, the researcher will calculate the progressive increase in 
weight (in percent) per each attempt for the subject for both trials. Based on this 





repetition at 85%, 90%, and 95%, of 1-RM, followed by the final attempt at either 100% 
or 100% and higher. 
For trial 1, the subject will be inhaling the assigned inhalant and attempting to lift 
100% 1-RM plus 2.5% of the 1-RM achieved in baseline testing.  In trial 2 the subject 
will be inhaling the same inhalant and attempting to lift 100% 1-RM plus 5%. In these 
two trials, the subject will be asked to set their feet and all other personal necessities prior 
to the lift, take in one maximal inhalation from either bottle one or two and perform the 
lift within 15 seconds of inhalation as the effects of the inhalant are felt.  Trials will then 
be repeated for the second inhalant with an identical process to Trial 1 and Trial 2 in Trial 
3. If subject fails an attempt, they will be allowed a second attempt at the weight with 
identical procedures, including another inhalation of the prescribed inhalant. All subjects 
will have a timed rest interval of three minutes between all attempts during this study for 
ideal recovery time without compromising performance.  
Warm-up for Each Trial 
1. 2 x 10 Fire Hydrants per leg 
2. 2 x 10 second Lunge Stretches 
3. 2 x 10 Dumbbell Good Mornings @ 10 & 20 pounds 
4. 1 x 10 @ Barbell 
5. 3 x 5 @ 45% 









 Trial 1 Methods x 2@ x 2@ x 1@ x 1@ x 1@ x 1@ N/A 
 Trial 2 Methods x 2@ x 2@ x 1@ x 1@ x 1@ x 1@ RM + 
2.5% 
 Trial 3 Methods  x 2 @ x 2@ x 1@ x 1@ x 1@ x 1@ RM + 
5% 
 
*** By utilizing the subject’s bodyweight in the following formula, it will provide 
another method of analyzing any improvement in strength due to the acute effects of the 
prescribed inhalant.  
 Performance= Load Lifted / Bodyweight.  Example- 445# / 190# bodyweight=2.34 score 
 
If you say YES, then your participation will last for 3 one-hour sessions with a minimum 
of 48 hours between sessions at the Old Dominion Student Recreation Center, room 
1006C and more specifically, the deadlift platform located within the facility. 
Approximately 19 other subjects will be participating in this study.  
EXCLUSIONARY CRITERIA 
All subjects are required to have a minimum of two years of resistance training 
experience to participate in this study.  Any subjects with a history of or exhibiting any 
cardiovascular issues including but not limited to asthma, lightheadedness, fainting, 
anaphylaxis, sickle cell traits, and other respiratory disorders will be kept from 







RISKS AND BENEFITS 
RISKS:  If you decide to participate in this study, then you may face a risk of muscle 
injury (sprains, ligament strains), spinal injuries (pinched nerves, herniated disks, etc.), 
hiatal hernias (rupture or tear in the abdominal cavity), or other injuries pertaining to 
muscular exhaustion and overexertion. There is also an inherited risk of fainting, rapid 
and involuntary contraction of the neck and head; and in significantly higher doses (not 
available in over-the-counter products, hence should not be an issue in this study) 
toxicity, sickness, and death. Ammonia levels will also be kept to minimal levels, far 
from the concentrated levels required to put subjects at risk for toxicity. And, as with any 
research, there is some possibility that you may be subject to risks that have not yet been 
identified. AED devices and center staff certified in first aid and CPR response will be on 
site, as well as the primary investigators also holding CPR, First Aid, and AED certified.  
BENEFITS: There are no direct benefits for participation in this study. 
COSTS AND PAYMENTS 
The researchers want your decision about participating in this study to be absolutely 
voluntary.  Yet they recognize that your participation may pose some cost to park to 
attend the trials, which there will be no assistance with. 
NEW INFORMATION 
If the researchers find new information during this study that would reasonably change 
your decision about participating, then they will give it to you. 
CONFIDENTIALITY 
The researchers will take steps to keep private information confidential, such as giving all 





locked office. The researcher will remove identifiers from the information, destroy tapes, 
store information in a locked filing cabinet prior to its processing. The results of this 
study may be used in reports, presentations, and publications; but the researcher will not 
identify you.  Of course, your records may be subpoenaed by court order or inspected by 




It is OK for you to say NO.  Even if you say YES now, you are free to say NO later, and 
walk away or withdraw from the study -- at any time. Your decision will not affect your 
relationship with Old Dominion University, or otherwise cause a loss of benefits to which 
you might otherwise be entitled. The researchers reserve the right to withdraw your 
participation in this study, at any time, if they observe potential problems with your 
continued participation. 
COMPENSATION FOR ILLNESS AND INJURY 
If you say YES, then your consent in this document does not waive any of your legal 
rights.  However, in the event of harm or injury arising from this study, neither Old 
Dominion University nor the researchers are able to give you any money, insurance 
coverage, free medical care, or any other compensation for such injury.  In the event that 
you suffer injury as a result of participation in any research project, you may contact Dr. 
David Branch at 757-683-4514, Dr. George Maihafer the current IRB chair at 757-
683-4520 at Old Dominion University, or the Old Dominion University Office of 






By signing this form, you are saying several things.  You are saying that you have read 
this form or have had it read to you, that you are satisfied that you understand this form, 
the research study, and its risks and benefits.  The researchers should have answered any 
questions you may have had about the research.  If you have any questions later on, then 
the researchers should be able to answer them: 
 
Justin Vigil 505-366-1257 
Dr. David Branch 757-683-4514 
Phil Sabatini 757-683-4995 
 
If at any time you feel pressured to participate, or if you have any questions about your 
rights or this form, then you should call Dr. George Maihafer, the current IRB chair, at 
757-683-4520, or the Old Dominion University Office of Research, at 757-683-3460. 
 
And importantly, by signing below, you are telling the researcher YES, that you agree to 















I certify that I have explained to this subject the nature and purpose of this research, 
including benefits, risks, costs, and any experimental procedures.  I have described the 
rights and protections afforded to human subjects and have done nothing to pressure, 
coerce, or falsely entice this subject into participating.  I am aware of my obligations 
under state and federal laws, and promise compliance.  I have answered the subject's 
questions and have encouraged him/her to ask additional questions at any time during the 





 Investigator's Printed Name & Signature 





















Warm-up for Each Trial 
1. 2 x 10 Fire Hydrants per leg 
2. 2 x 10 second Lunge Stretches 
3. 2 x 10 Dumbbell Good Mornings @ 10 & 20 pounds 
4. 1 x 10 @ Barbell 
5. 3 x 5 @ 45% 














65% 75% 85% 90% 95% 100% Trial 
 Trial 1 Methods x 2@ x 2@ x 1@ x 1@ x 1@ x 1@ N/A 
 Trial 2 Methods x 2@ x 2@ x 1@ x 1@ x 1@ x 1@ RM + 
2.5% 
 Trial 3 Methods  x 2 @ x 2@ x 1@ x 1@ x 1@ x 1@ RM + 
5% 
 
*** By utilizing the subject’s bodyweight in the following formula, it will provide 
another method of analyzing any improvement in strength due to the acute effects of the 
prescribed inhalant.  
 Performance= Load Lifted / Bodyweight.  Example- 445# / 190# bodyweight=2.34 score 
Achieved Trial 1 Weights: 
Baseline 1-RM achieved:  
 65% 75% 85% 90% 95% 100% 102.5% 105% 107.5% 
 Trial 2 
“A”  
         
Success Y / N Y / N Y / N Y / N Y / N Y / N Y / N Y / N Y / N 
 Trial 3 
“B” 
         





EXERCISE TEST SCREENING QUESTIONNAIRE 
 Read the questions to potential subjects and interpret the responses. Do not have 
the person fill out the questionnaire 
on his/her own. 
ID # __________________________ Sex _____ Age _____ Date _______________ 
I. Risk Factors 
___ 1. 
___ 2. ___ 3. ___ 4. 
___ 5. ___ 6. ___ 7. 
Do you have a family history of heart disease? [heart attack, bypass surgery, angioplasty 
or sudden death prior to the age of 55 (father or brother) or 65 (mother or sister)] Have 
you smoked cigarettes in the past 6 months? Do you know if your blood pressure is 
typically 140/90 or more? Do you take blood pressure medication? 
Do you know if your LDL cholesterol is more than 130, or if your HDL cholesterol is 
less than 40? If you don’t know your LDL, do you know if you total cholesterol is more 
than 200? Do you know if your fasting glucose is more than 100? What is your height 
and weight? [determine if BMI is > 30] 
Do you usually obtain at least 30 minutes of moderate intensity physically activity most 






___ 1. ___ 2. ___ 3. ___ 4. ___ 5. ___ 6. ___ 7. ___ 8. 
Do you ever have pain or discomfort in your chest or surrounding areas? (i.e., ischemia) 
Do you ever feel faint or dizzy? (Other than when sitting up rapidly) Do you find it 
difficult to breathe when you are lying down or sleeping? Do your ankles ever become 
swollen? (Other than after a long period of standing) 
Do you ever have heart palpitations, or an unusual period of rapid heart rate? Do you 
ever experience pain in your legs? (i.e., fragmented claudication) Has a physician ever 
said you have a heart murmur? (If yes, has he/she said it is OK, and safe for you to 




___ 2. ___ 3. ___ 4. 
Do you have any of the following diseases? Heart disease, peripheral vascular disease, 
cerebrovascular disease, chronic obstructive pulmonary disease (emphysema or chronic 
bronchitis) asthma (chronic), interstitial lung disease, cystic fibrosis, diabetes mellitus, 
thyroid disorder, renal disease, or liver disease (For women) Do you think you may be 
pregnant? Are you taking any medications, such as blood pressure medication, that 





you to do strenuous exercise? 
Eligible for study if: Is between 18-35 years old, has no more than 1 risk factor from 
section I, has none of the symptoms in section II, and answers “No” to all questions in 
section III. 
Note: For individuals who do not know their blood glucose or blood lipid values, the 
ACSM assumes they have those risk factors if they are males over 44 years of age or 
females over 54 years of age, and assumes they do not have those risk factors if they are 
younger. Since all subjects in the current study will be 35 years old or less, if they do not 
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